CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Atenolol

阿替洛尔 杂质对照品Atenolol Impurities

EPUSP41 个杂质条目41 impurity entries

本页汇总 阿替洛尔 的 41 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 41 impurity reference standards of Atenolol with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 阿替洛尔(Atenolol)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSonochemical degradation of a pharmaceutical waste, atenolol, in aqueous medium
    Environmental science and pollution research international · 2014 · Nejumal KK et al.  ·  PMID 24306722  ·  DOI
  2. 杂质研究Impurity studiesHazard screening of photo-transformation products from pharmaceuticals: Application to selective β(1)-blockers atenolol and metoprolol
    The Science of the total environment · 2017 · Toolaram AP et al.  ·  PMID 27939084  ·  DOI
  3. 杂质研究Impurity studiesCharacterization of atenolol transformation products on light-activated TiO2 surface by high-performance liquid chromatography/high-resolution mass spectrometry
    Rapid communications in mass spectrometry : RCM · 2008 · Medana C et al.  ·  PMID 18181246  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisSustainable Synthesis of the Active Pharmaceutical Ingredient Atenolol in Deep Eutectic Solvents
    International journal of molecular sciences · 2024 · Procopio D et al.  ·  PMID 38928384  ·  DOI
  • 合成方法SynthesisSynthesis of Enantiopure (S)-Atenolol by Utilization of Lipase-Catalyzed Kinetic Resolution of a Key Intermediate
    International journal of molecular sciences · 2024 · Hansen MB et al.  ·  PMID 38542467  ·  DOI

阿替洛尔 —— 原料药与杂质对照品Atenolol — drug substance & impurities

共 42 个条目(含原料药本体)42 items incl. the drug substance
Atenolol structure
EP原料药 APIAPI
阿替洛尔Atenolol
Atenolol
CAS No.29122-68-7
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity A (Atenolol USP Related Compound A structure
EPA
阿替洛尔杂质1 (阿替洛尔EP杂质A)Atenolol EP Impurity A (Atenolol USP Related Compound A
Atenolol EP Impurity A (Atenolol USP Related Compound A
CAS No.17194-82-0
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity B (Atenolol USP Related Compound B) structure
EPB
阿替洛尔杂质2(阿替洛尔EP杂质B)Atenolol EP Impurity B (Atenolol USP Related Compound B)
Atenolol EP Impurity B (Atenolol USP Related Compound B)
CAS No.61698-76-8
Chemical FormulaC11H15NO4
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity D (Atenolol USP Related Compound D) structure
EPD
阿替洛尔杂质4 (阿替洛尔EP杂质D)Atenolol EP Impurity D (Atenolol USP Related Compound D)
Atenolol EP Impurity D (Atenolol USP Related Compound D)
CAS No.115538-83-5
Chemical FormulaC11H14ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity E (Atenolol USP Related Compound E) structure
EPE
阿替洛尔杂质5(阿替洛尔EP杂质E)Atenolol EP Impurity E (Atenolol USP Related Compound E)
Atenolol EP Impurity E (Atenolol USP Related Compound E)
CAS No.141650-31-9
Chemical FormulaC19H22N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity F (Atenolol USP Related Compound F) (Mixture of Diastereomers) structure
EPF
阿替洛尔杂质6(阿替洛尔EP杂质F)Atenolol EP Impurity F (Atenolol USP Related Compound F) (Mixture of Diastereomers)
Atenolol EP Impurity F (Atenolol USP Related Compound F) (Mixture of Diastereomers)
CAS No.87619-83-8
Chemical FormulaC25H35N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity G (Atenolol USP Related Compound G) structure
EPG
阿替洛尔杂质7 (阿替洛尔EP杂质G)Atenolol EP Impurity G (Atenolol USP Related Compound G)
Atenolol EP Impurity G (Atenolol USP Related Compound G)
CAS No.56392-14-4
Chemical FormulaC14H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity G Sodium Salt (Atenolol USP Related Compound G Sodium Salt) structure
EPG
阿替洛尔EP杂质GAtenolol EP Impurity G Sodium Salt (Atenolol USP Related Compound G Sodium Salt)
Atenolol EP Impurity G Sodium Salt (Atenolol USP Related Compound G Sodium Salt)
CAS No.—
Chemical FormulaC14H20NO4.Na
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity H structure
EPH
阿替洛尔杂质8(阿替洛尔EP杂质H)Atenolol EP Impurity H
Atenolol EP Impurity H
CAS No.29277-73-4
Chemical FormulaC14H20N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity I structure
EPI
阿替洛尔杂质9(阿替洛尔EP杂质I)Atenolol EP Impurity I
Atenolol EP Impurity I
CAS No.1797116-92-7
Chemical FormulaC13H20N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol EP Impurity J structure
EPJ
阿替洛尔杂质11(阿替洛尔EP杂质J)Atenolol EP Impurity J
Atenolol EP Impurity J
CAS No.81346-71-6
Chemical FormulaC11H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol USP Related Compound C structure
USPC
阿替洛尔杂质3(阿替洛尔EP杂质C)Atenolol USP Related Compound C
Atenolol USP Related Compound C
CAS No.29122-69-8
Chemical FormulaC11H13NO3
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atenolol structure
—
阿替洛尔杂质20 (N-亚硝基阿替洛尔)N-Nitroso Atenolol
N-Nitroso Atenolol
CAS No.134720-04-0
Chemical FormulaC14H21N3O4
Purity>95%询价On request
10mg25mg50mg100mg
2-Hydroxy Atenolol structure
—
2-Hydroxy Atenolol
CAS No.—
Chemical FormulaCASNo.N/A
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Glucuronide structure
—
Atenolol Glucuronide
CAS No.—
Chemical FormulaCASNo.N/A
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Atenolol-d7 structure
—
N-Nitroso Atenolol-d7
CAS No.—
Chemical FormulaC14H14D7N3O4
Purity>95%询价On request
Atenolol Impurity 1 structure
1
阿替洛尔杂质12Atenolol Impurity 1
Atenolol Impurity 1
CAS No.156-38-7
Chemical FormulaC8H8O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 2 structure
2
阿替洛尔杂质2Atenolol Impurity 2
Atenolol Impurity 2
CAS No.—
Chemical FormulaC11H15NO4
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 10(Cyano Epoxide) structure
10
阿替洛尔杂质10(氰基环氧化物)Atenolol Impurity 10(Cyano Epoxide)
Atenolol Impurity 10(Cyano Epoxide)
CAS No.35198-42-6
Chemical FormulaC11H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 13 structure
13
阿替洛尔杂质13Atenolol Impurity 13
Atenolol Impurity 13
CAS No.14199-15-6
Chemical FormulaC9H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 14 structure
14
阿替洛尔杂质14Atenolol Impurity 14
Atenolol Impurity 14
CAS No.6547-53-1
Chemical FormulaC15H14O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 15 ((R)-Atenolol) structure
15
阿替洛尔杂质15 ((R)-阿替洛尔)Atenolol Impurity 15 ((R)-Atenolol)
Atenolol Impurity 15 ((R)-Atenolol)
CAS No.56715-13-0
Chemical FormulaC14H22N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 16 structure
16
阿替洛尔杂质16Atenolol Impurity 16
Atenolol Impurity 16
CAS No.3583-58-2
Chemical FormulaC10H12O2S
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 17 structure
17
阿替洛尔杂质17Atenolol Impurity 17
Atenolol Impurity 17
CAS No.55863-28-0
Chemical FormulaC10H12O2S
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 18 structure
18
阿替洛尔杂质18Atenolol Impurity 18
Atenolol Impurity 18
CAS No.7339-87-9
Chemical FormulaC8H8O2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 19 structure
19
阿替洛尔杂质19Atenolol Impurity 19
Atenolol Impurity 19
CAS No.22048-71-1
Chemical FormulaC12H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 21 structure
21
阿替洛尔杂质21Atenolol Impurity 21
Atenolol Impurity 21
CAS No.949293-84-9
Chemical FormulaC5H6N2O2S
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 22 structure
22
阿替洛尔杂质22Atenolol Impurity 22
Atenolol Impurity 22
CAS No.1006729-91-4
Chemical FormulaC11H15NO3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 23 structure
23
阿替洛尔杂质23Atenolol Impurity 23
Atenolol Impurity 23
CAS No.142037-04-5
Chemical FormulaC11H12ClNO2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 24 structure
24
阿替洛尔杂质24Atenolol Impurity 24
Atenolol Impurity 24
CAS No.72224-25-0
Chemical FormulaC11H12O4
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 36 structure
36
阿替洛尔杂质36Atenolol Impurity 36
Atenolol Impurity 36
CAS No.22446-41-9
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 37 structure
37
阿替洛尔杂质37Atenolol Impurity 37
Atenolol Impurity 37
CAS No.5633-43-2
Chemical FormulaC16H14O5
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 38 structure
38
阿替洛尔杂质38Atenolol Impurity 38
Atenolol Impurity 38
CAS No.875875-62-0
Chemical FormulaC16H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 39 structure
39
阿替洛尔杂质39Atenolol Impurity 39
Atenolol Impurity 39
CAS No.22446-40-8
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 40 structure
40
阿替洛尔杂质40Atenolol Impurity 40
Atenolol Impurity 40
CAS No.1006729-98-1
Chemical FormulaC14H22N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 41 structure
41
阿替洛尔杂质41Atenolol Impurity 41
Atenolol Impurity 41
CAS No.1197-55-3
Chemical FormulaC8H9NO2
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 42 structure
42
阿替洛尔杂质42Atenolol Impurity 42
Atenolol Impurity 42
CAS No.104-01-8
Chemical FormulaC9H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 43 structure
43
阿替洛尔杂质43Atenolol Impurity 43
Atenolol Impurity 43
CAS No.23786-14-3
Chemical FormulaC10H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 44 structure
44
阿替洛尔杂质44Atenolol Impurity 44
Atenolol Impurity 44
CAS No.1798-09-0
Chemical FormulaC9H10O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 45 structure
45
阿替洛尔杂质45Atenolol Impurity 45
Atenolol Impurity 45
CAS No.942-97-2
Chemical FormulaC10H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 46 structure
46
阿替洛尔杂质46Atenolol Impurity 46
Atenolol Impurity 46
CAS No.4513-73-9
Chemical FormulaC10H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Atenolol Impurity 51 structure
51
阿替洛尔杂质51Atenolol Impurity 51
Atenolol Impurity 51
CAS No.92966-74-0
Chemical FormulaC16H16N2O3
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

阿替洛尔 —— 研究文献与合成路线Atenolol — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 阿替洛尔 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Atenolol. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Simultaneous separation of atenolol enantiomers and its acid/alkaline degradation impurities on mixed-mode chiral ligand exchange stationary phases
    Bai H, Chen L · Chirality · 2021 · 被引 3cited 3
  2. A comparative study on Fe(III)/H2O2 and Fe(III)/S2O82- systems modified by catechin for the degradation of atenolol
    Yan J, Brigante M, Mailhot G, et al. · Chemosphere · 2023 · 被引 1cited 1
  3. Comprehensive and Validated Chromatographic Techniques for the Estimation of Lercanidipine Hydrochloride and Atenolol in Bulk and Combined Dosage Form in the Presence of Lercanidipine Degradation Products with LC/MS Characterization
    Boltia SA, Fattah TA, Saad MT, et al. · Journal of chromatographic science · 2024
  4. Degradation characteristics of p-nitrophenol and atenolol by carbon nitride modified by graphene quantum dots
    Zhang Y, Yang S, Wei L, et al. · Environmental technology · 2024
  5. Oxidative treatments for atenolol removal in water: Elucidation by mass spectrometry and toxicity evaluation of degradation products
    Quaresma AV, Sousa BA, Silva KTS, et al. · Rapid communications in mass spectrometry : RCM · 2019 · 被引 16cited 16
  6. A simple, selective, and sensitive gas chromatography-mass spectrometry method for the analysis of five process-related impurities in atenolol bulk drug and capsule formulations
    Reddy AVB, Yusop Z, Jaafar J, et al. · Journal of separation science · 2017 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. PROCESS FOR THE PREPARATION OF OPTICALLY PURE CHIRAL ATENOLOL
    AUH JIN, WON DUK KWON, MOON BYUNG HYUN, JONG CHANG WOO, et al. · 公开号 KR20090080927KR20090080927 · 2009
  2. PROCESS FOR THE PREPARATION OF OPTICALLY PURE CHIRAL ATENOLOL
    AUH JIN, WON DUK KWON, MOON BYUNG HYUN, JONG CHANG WOO, et al. · 公开号 KR20090080657KR20090080657 · 2009
  3. Preparation method of s-atenolol
    OH SANG BONG, CHOI HWAN, CHAI KI BYUNG · 公开号 KR100900573BKR100900573B · 2009
  4. Atenolol sustained-release dropping pill and preparation method thereof
    YUNZHI QU · 公开号 CN101269027CN101269027 · 2008
  5. Atenolol frozen dry injecta and preparing method
    ZENG CHUIYU ZHANG · 公开号 CN101023938CN101023938 · 2007

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

阿替洛尔 杂质谱研究要点Atenolol — impurity profiling notes

下面这些是拿到 阿替洛尔 的 42 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 42 impurity entries for Atenolol, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances